Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Combined Conditioned Medium With Umbilical Cord Mesenchymal Stem Cells as A Novel Strategy for Acute Stroke Infarct

NCT05008588 is registered in ClinicalTrials.gov with PT. Prodia Stem Cell Indonesia as lead sponsor.

NCT NCT05008588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05008588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Combined Conditioned Medium With Umbilical Cord Mesenchymal Stem Cells as A Novel Strategy for Acute Stroke Infarct
Lead sponsor
PT. Prodia Stem Cell Indonesia
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
May 30, 2022
Completion date
March 31, 2026
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke